KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares OutstandingShares Outstanding
Ratios

Organon (OGN) EBIAT (2020 - 2026)

Organon has reported EBIAT over the past 7 years, most recently at $146.0 million for Q1 2026.

  • For Q1 2026, EBIAT rose 67.82% year-over-year to $146.0 million; the TTM value through Mar 2026 reached $246.0 million, down 67.2%, while the annual FY2025 figure was $187.0 million, 78.36% down from the prior year.
  • EBIAT for Q1 2026 was $146.0 million at Organon, up from -$205.0 million in the prior quarter.
  • Over five years, EBIAT peaked at $546.0 million in Q4 2023 and troughed at -$205.0 million in Q4 2025.
  • A 5-year average of $184.5 million and a median of $177.0 million in 2023 define the central range for EBIAT.
  • Biggest five-year swings in EBIAT: skyrocketed 518.97% in 2024 and later plummeted 288.07% in 2025.
  • Year by year, EBIAT stood at $108.0 million in 2022, then surged by 405.56% to $546.0 million in 2023, then tumbled by 80.04% to $109.0 million in 2024, then plummeted by 288.07% to -$205.0 million in 2025, then soared by 171.22% to $146.0 million in 2026.
  • Business Quant data shows EBIAT for OGN at $146.0 million in Q1 2026, -$205.0 million in Q4 2025, and $160.0 million in Q3 2025.